NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pandorum Technologies

Pandorum Technologies

Private
BangaloreHealthcare & Life Scienceshttps://pandorum.com/

Last Round

Series B

Feb 9, 2026

Est. Valuation

$91M

Total Funding Raised

$32.41M

Company Overview

Pandorum Technologies is a biotechnology company that specializes in tissue engineering and regenerative medicine through the development of functional human tissues and exosome-based therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, 3D Printing, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

tissue engineeringregenerative medicinebio-printingexosome therapeuticscorneal regenerationbiotechdrug discovery3D tissue modelsbio-materialscellular engineeringlab-grown tissueliquid corneacontract researchorgan-on-a-chipbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pandorum Technologies Comps

Public and private peers based on sector, stage, and business model.

Pandorum Technologies comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pandorum Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 9, 2026
VC RoundMar 15, 2024
Series B ExtensionOct 19, 2021
Series BSep 10, 2020
Series AFeb 14, 2018
Angel
Dec 24, 2016

Pandorum Technologies Investors

Notable investors and investment history

Pandorum Technologies investors
InvestorRounds
IAN GroupVC Round, Series B, Series A
Biotechnology Industry Research Assistance CouncilGrant
500 GlobalSeries A
021 CapitalSeries B, Series A
Kotak Investment AdvisorsSeries B
KITVEN Fund 3 BiotechSeries B
Burman Family HoldingsSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 7, 2026

    Partnered with Nucelion to scale exosome manufacturing in the APAC region.

  • Oct 1, 2025

    Preparing IND-enabling programs for FDA submissions, advancing towards clinical trials.

Pandorum Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pandorum Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pandorum Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersBangalore
Employee Range44
Year Founded2011
Last FundingFeb 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.